Valuation: Certara, Inc.

Market Cap 1.68B 1.51B 1.38B 1.25B 2.35B 160B 2.39B 16.51B 6.63B 83.96B 6.31B 6.17B 265B P/E 2026 *
-49.7x
P/E 2027 * 186x
Enterprise Value 1.74B 1.56B 1.43B 1.3B 2.43B 165B 2.47B 17.1B 6.87B 86.95B 6.53B 6.39B 274B EV / Sales 2026 *
4.59x
EV / Sales 2027 * 4.27x
Free-Float
67.08%
Yield 2026 *
-
Yield 2027 * -
1 day-1.61%
1 week+6.68%
1 month+19.78%
3 months+36.05%
6 months+79.77%
Current year+25.09%
1 week 10.08
Extreme 10.0793
11.73
1 month 8.58
Extreme 8.58
11.73
Current year 4.45
Extreme 4.45
11.73
1 year 4.45
Extreme 4.45
11.88
3 years 4.45
Extreme 4.45
19.87
5 years 4.45
Extreme 4.45
45.48
10 years 4.45
Extreme 4.45
45.48
Manager TitleAgeSince
Chief Executive Officer 53 01/01/2026
Director of Finance/CFO 53 15/07/2026
Chief Tech/Sci/R&D Officer - 31/07/2025
Director TitleAgeSince
Chairman 72 01/12/2021
Director/Board Member 68 01/01/2013
Director/Board Member 59 01/08/2017
Date Insider Type Main position Quantity % Market Cap. Importance
01/09/26 Free

Chief Financial Officer

63,532 0.0416%
15/07/26 Other

Chief Financial Officer

191,850 0.1233%
01/06/26 Exercice

General Counsel

57,763 0.0371%
Change 5-day change 1-year change 3-year change Capi.($)
-1.61%+6.68%-5.25%-9.60% 1.68B
-1.55%-0.50%+0.79%+54.36% 3,876B
-6.27%-6.42%-8.16%+1,143.99% 442B
-6.37%+3.57%-50.24%+26.37% 396B
-3.86%-3.86%+66.12%+201.10% 300B
+1.12%-1.47%-5.88%+66.68% 272B
-4.10%-2.77%+84.48%+466.68% 257B
-4.15%-33.87%-42.82%-9.67% 109B
-2.17%-24.40%+57.45%+138.03% 99.98B
+0.85%-5.15%-26.47%-52.97% 97.39B
Average -2.81%-6.82%+7.00%+202.50% 585.13B
Weighted average by Cap. -2.36%-2.09%+3.07%+159.48%

Financials

2026 *2027 *
Net sales 379M 339M 312M 283M 529M 35.99B 539M 3.72B 1.49B 18.93B 1.42B 1.39B 59.71B 389M 348M 320M 290M 543M 36.92B 553M 3.82B 1.53B 19.42B 1.46B 1.43B 61.24B
Net income -30.84M -27.62M -25.4M -23.02M -43.03M -2.93B -43.83M -303M -122M -1.54B -116M -113M -4.86B 4.02M 3.6M 3.31M 3M 5.61M 382M 5.72M 39.51M 15.86M 201M 15.09M 14.77M 633M
Net Debt 59.79M 53.54M 49.25M 44.63M 83.42M 5.68B 84.98M 587M 236M 2.99B 224M 220M 9.42B -19.92M -17.84M -16.41M -14.87M -27.8M -1.89B -28.32M -196M -78.57M -995M -74.77M -73.18M -3.14B
Projected Income Statement - Annual - Certara, Inc.
Logo Certara, Inc.
Certara, Inc. is a provider of biosimulation science, technology, and consulting services for using Model-Informed Drug Development (MIDD) in the global biopharmaceutical and biotech industry. The Company's proprietary biosimulation platforms are built on biology, chemistry, and pharmacology principles with proprietary mathematical algorithms that model how medicines and diseases behave in the body. It has developed scientifically-based solutions for the collection, standardization, validation, storage, and analysis of the preclinical, clinical and evidence data needed for MIDD. These data solutions are used internally and industry-wide by life sciences companies. The Company applies AI capabilities within established modeling environments and under the supervision of experienced scientists and regulatory experts. Its modeling platforms and curated datasets position it to incorporate emerging AI techniques in a controlled and scientifically rigorous manner.
Employees
1,546
Date Price Change Volume
30/10/26 $11.02 -1.61% 1,946,480
29/10/26 $11.20 -2.44% 2,749,164
28/10/26 $11.48 +4.84% 2,370,661
27/10/26 $10.95 +3.20% 2,416,975
26/10/26 $10.61 +2.71% 2,348,221
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AA
MarketScreener Ratings - Certara, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
11.02USD
Average target price
9.168USD
Spread / Average Target
-16.80%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Certara, Inc.
  1. Stock Market
  2. Stocks
  3. CERT Stock